Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation.
Saved in:
| Title: | Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation. |
|---|---|
| Authors: | Tan JQE; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; SA Pharmacy, SA Health, Adelaide, South Australia, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Modi ND; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide, Australia., Hassankhani R; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Martin H; SA Pharmacy, SA Health, Adelaide, South Australia, Australia., Dyk MV; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Spencer S; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Sallustio BC; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.; Discipline of Pharmacology, School of Biomedicine, The University of Adelaide, Adelaide, Australia., Kichenadasse G; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun 11, pp. 10781552261459659. Date of Electronic Publication: 2026 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
